ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients

PURPOSE: Mutations in the estrogen receptor-alpha (ER) gene, ESR1, have been identified in breast cancer metastases after progression on endocrine therapies. Due to limitations of metastatic biopsies, the reported frequency of ESR1 mutations may be underestimated. Here, we show a high frequency of E...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Chu, David, Paoletti, Costanza, Gersch, Christina, VanDenBerg, Dustin A., Zabransky, Daniel J., Cochran, Rory L., Wong, Hong Yuen, Toro, Patricia Valda, Cidado, Justin, Croessmann, Sarah, Erlanger, Bracha, Cravero, Karen, Kyker-Snowman, Kelly, Button, Berry, Parsons, Heather, Dalton, W. Brian, Gillani, Riaz, Medford, Arielle, Aung, Kimberly, Tokudome, Nahomi, Chinnaiyan, Arul M., Schott, Anne, Robinson, Dan, Jacks, Karen S., Lauring, Josh, Hurley, Paula, Hayes, Daniel F., Rae, James, Park, Ben Ho
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4993201/
https://ncbi.nlm.nih.gov/pubmed/26261103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0943
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items